Osteoporosis in women: prevention and treatment (Q77445325)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9782696 AND SRC:MED&resulttype=core&format=json

5 December 2019

review article

1 reference

title

Osteoporosis in women: prevention and treatment (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9782696 AND SRC:MED&resulttype=core&format=json

5 December 2019

author name string

L Willhite

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9782696 AND SRC:MED&resulttype=core&format=json

5 December 2019

publication date

1 September 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9782696 AND SRC:MED&resulttype=core&format=json

Journal of the American Pharmacists Association

5 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9782696 AND SRC:MED&resulttype=core&format=json

5 December 2019

volume

38

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9782696 AND SRC:MED&resulttype=core&format=json

5 December 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9782696 AND SRC:MED&resulttype=core&format=json

5 December 2019

page(s)

614-23; quiz 623-4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9782696 AND SRC:MED&resulttype=core&format=json

Prevalence of Low Femoral Bone Density in Older U.S. Adults from NHANES III

5 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016/S1086-5802(16)30376-X

7 January 2021

Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: Synopsis of a WHO report

1 reference

https://api.crossref.org/works/10.1016/S1086-5802(16)30376-X

7 January 2021

The worldwide problem of osteoporosis: insights afforded by epidemiology

1 reference

https://api.crossref.org/works/10.1016/S1086-5802(16)30376-X

7 January 2021

The dilemma of osteoporosis in men.

1 reference

https://api.crossref.org/works/10.1016/S1086-5802(16)30376-X

7 January 2021

Functional Recovery Following Hip Fracture in the Elderly

1 reference

https://api.crossref.org/works/10.1016/S1086-5802(16)30376-X

7 January 2021

Medical Expenditures for the Treatment of Osteoporotic Fractures in the United States in 1995: Report from the National Osteoporosis Foundation

1 reference

https://api.crossref.org/works/10.1016/S1086-5802(16)30376-X

7 January 2021

Bone marrow, cytokines, and bone remodeling. Emerging insights into the pathophysiology of osteoporosis

1 reference

https://api.crossref.org/works/10.1016/S1086-5802(16)30376-X

7 January 2021

Cytokines and estrogen in bone: anti-osteoporotic effects

1 reference

https://api.crossref.org/works/10.1016/S1086-5802(16)30376-X

7 January 2021

The relative contributions of age and years since menopause to postmenopausal bone loss

1 reference

https://api.crossref.org/works/10.1016/S1086-5802(16)30376-X

7 January 2021

The prevention and treatment of osteoporosis

1 reference

https://api.crossref.org/works/10.1016/S1086-5802(16)30376-X

7 January 2021

Hip fractures in men.

1 reference

https://api.crossref.org/works/10.1016/S1086-5802(16)30376-X

7 January 2021

Factors associated with appendicular bone mass in older women. The Study of Osteoporotic Fractures Research Group

1 reference

https://api.crossref.org/works/10.1016/S1086-5802(16)30376-X

7 January 2021

Results of bone densitometry affect women's decisions about taking measures to prevent fractures

1 reference

https://api.crossref.org/works/10.1016/S1086-5802(16)30376-X

7 January 2021

Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis. American College of Rheumatology Task Force on Osteoporosis Guidelines

1 reference

https://api.crossref.org/works/10.1016/S1086-5802(16)30376-X

7 January 2021

Calcium for Prevention of Osteoporotic Fractures in Postmenopausal Women

1 reference

https://api.crossref.org/works/10.1016/S1086-5802(16)30376-X

7 January 2021

Rationale for active vitamin D analog therapy in senile osteoporosis.

1 reference

https://api.crossref.org/works/10.1016/S1086-5802(16)30376-X

7 January 2021

Effect of Calcium and Vitamin D Supplementation on Bone Density in Men and Women 65 Years of Age or Older

1 reference

https://api.crossref.org/works/10.1016/S1086-5802(16)30376-X

7 January 2021

Vitamin D3 and calcium to prevent hip fractures in elderly women

1 reference

https://api.crossref.org/works/10.1016/S1086-5802(16)30376-X

7 January 2021

Vitamin D supplementation and fracture incidence in elderly persons. A randomized, placebo-controlled clinical trial

1 reference

https://api.crossref.org/works/10.1016/S1086-5802(16)30376-X

7 January 2021

Calcium metabolism in postmenopausal osteoporotic women is determined by dietary calcium and coffee intake

1 reference

https://api.crossref.org/works/10.1016/S1086-5802(16)30376-X

7 January 2021

Exercise-associated amenorrhea, low bone density, and estrogen replacement therapy

1 reference

https://api.crossref.org/works/10.1016/S1086-5802(16)30376-X

7 January 2021

Cigarette smoking and bone mineral density in older men and women

1 reference

https://api.crossref.org/works/10.1016/S1086-5802(16)30376-X

7 January 2021

Risk factors for hip fracture in men. Hip Fracture Study Group

1 reference

https://api.crossref.org/works/10.1016/S1086-5802(16)30376-X

7 January 2021

The bone density of female twins discordant for tobacco use

1 reference

https://api.crossref.org/works/10.1016/S1086-5802(16)30376-X

7 January 2021

https://api.crossref.org/works/10.1016/S1086-5802(16)30376-X

1 reference

7 January 2021

Patient-specific decisions about hormone replacement therapy in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016/S1086-5802(16)30376-X

7 January 2021

Estrogen use and cardiovascular disease.

1 reference

https://api.crossref.org/works/10.1016/S1086-5802(16)30376-X

7 January 2021

Use of menopausal estrogens and medroxyprogesterone in the United States, 1982-1992.

1 reference

https://api.crossref.org/works/10.1016/S1086-5802(16)30376-X

7 January 2021

Compliance with hormone therapy

1 reference

https://api.crossref.org/works/10.1016/S1086-5802(16)30376-X

7 January 2021

Effect of bone density information on decisions about hormone replacement therapy: a randomized trial

1 reference

https://api.crossref.org/works/10.1016/S1086-5802(16)30376-X

7 January 2021

Consensus development conference: diagnosis, prophylaxis, and treatment of osteoporosis

1 reference

https://api.crossref.org/works/10.1016/S1086-5802(16)30376-X

7 January 2021

Estrogen therapy arrests bone loss in elderly women

1 reference

https://api.crossref.org/works/10.1016/S1086-5802(16)30376-X

7 January 2021

Hormone Replacement Therapy: Management of Common Problems

1 reference

https://api.crossref.org/works/10.1016/S1086-5802(16)30376-X

7 January 2021

Hormone replacement therapy in the elderly

1 reference

https://api.crossref.org/works/10.1016/S1086-5802(16)30376-X

7 January 2021

Hormone therapy to prevent disease and prolong life in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016/S1086-5802(16)30376-X

7 January 2021

Timing of postmenopausal estrogen for optimal bone mineral density. The Rancho Bernardo Study

1 reference

https://api.crossref.org/works/10.1016/S1086-5802(16)30376-X

7 January 2021

The effect of postmenopausal estrogen therapy on bone density in elderly women

1 reference

https://api.crossref.org/works/10.1016/S1086-5802(16)30376-X

7 January 2021

Estrogen: effects on the cardiovascular tree

1 reference

https://api.crossref.org/works/10.1016/S1086-5802(16)30376-X

7 January 2021

Hormone replacement therapy lowers plasma Lp(a) concentrations. Comparison of cyclic transdermal and continuous estrogen-progestin regimens

1 reference

https://api.crossref.org/works/10.1016/S1086-5802(16)30376-X

7 January 2021

A comparison of estrogen replacement, pravastatin, and combined treatment for the management of hypercholesterolemia in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016/S1086-5802(16)30376-X

7 January 2021

Postmenopausal Estrogen and Progestin Use and the Risk of Cardiovascular Disease

1 reference

https://api.crossref.org/works/10.1016/S1086-5802(16)30376-X

7 January 2021

Postmenopausal hormone therapy and mortality.

1 reference

https://api.crossref.org/works/10.1016/S1086-5802(16)30376-X

7 January 2021

Postmenopausal hormone therapy and breast cancer

1 reference

https://api.crossref.org/works/10.1016/S1086-5802(16)30376-X

7 January 2021

Estrogen replacement therapy in breast cancer survivors. A time for change. Breast Cancer Committees of the Eastern Cooperative Oncology Group.

1 reference

https://api.crossref.org/works/10.1016/S1086-5802(16)30376-X

7 January 2021

Estrogen replacement therapy and protection from acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016/S1086-5802(16)30376-X

7 January 2021

Hormone replacement therapy and risk of venous thromboembolism: population based case-control study

1 reference

https://api.crossref.org/works/10.1016/S1086-5802(16)30376-X

7 January 2021

Risk of endometrial cancer after tamoxifen treatment of breast cancer

1 reference

https://api.crossref.org/works/10.1016/S1086-5802(16)30376-X

7 January 2021

Effects of Raloxifene on Bone Mineral Density, Serum Cholesterol Concentrations, and Uterine Endometrium in Postmenopausal Women

1 reference

https://api.crossref.org/works/10.1016/S1086-5802(16)30376-X

7 January 2021

Effects of tamoxifen on bone mineral density in postmenopausal women with breast cancer

1 reference

https://api.crossref.org/works/10.1016/S1086-5802(16)30376-X

7 January 2021

Effects of Raloxifene on Serum Lipids and Coagulation Factors in Healthy Postmenopausal Women

1 reference

https://api.crossref.org/works/10.1016/S1086-5802(16)30376-X

7 January 2021

Fatal myocardial infarction in the Scottish adjuvant tamoxifen trial. The Scottish Breast Cancer Committee

1 reference

https://api.crossref.org/works/10.1016/S1086-5802(16)30376-X

7 January 2021

Coronary heart disease mortality and adjuvant tamoxifen therapy

1 reference

https://api.crossref.org/works/10.1016/S1086-5802(16)30376-X

7 January 2021

Cyclic etidronate: has the rose lost its bloom?

1 reference

https://api.crossref.org/works/10.1016/S1086-5802(16)30376-X

7 January 2021

Prevention of nonvertebral fractures by alendronate. A meta-analysis. Alendronate Osteoporosis Treatment Study Groups

1 reference

https://api.crossref.org/works/10.1016/S1086-5802(16)30376-X

7 January 2021

Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group

1 reference

https://api.crossref.org/works/10.1016/S1086-5802(16)30376-X

7 January 2021

Treatment with alendronate prevents fractures in women at highest risk: results from the Fracture Intervention Trial

1 reference

https://api.crossref.org/works/10.1016/S1086-5802(16)30376-X

7 January 2021

Increments in Bone Mineral Density of the Lumbar Spine and Hip and Suppression of Bone Turnover Are Maintained after Discontinuation of Alendronate in Postmenopausal Women

1 reference

https://api.crossref.org/works/10.1016/S1086-5802(16)30376-X

7 January 2021

Prevention of bone loss with alendronate in postmenopausal women under 60 years of age. Early Postmenopausal Intervention Cohort Study Group.

1 reference

https://api.crossref.org/works/10.1016/S1086-5802(16)30376-X

7 January 2021

Calcitonin and its antinociceptive activity: animal and human investigations 1975-1992.

1 reference

https://api.crossref.org/works/10.1016/S1086-5802(16)30376-X

7 January 2021

Treatment of Postmenopausal Osteoporosis with Slow-Release Sodium Fluoride: Final Report of a Randomized Controlled Trial

1 reference

https://api.crossref.org/works/10.1016/S1086-5802(16)30376-X

7 January 2021

Current and potential future drug treatments for osteoporosis

1 reference

https://api.crossref.org/works/10.1016/S1086-5802(16)30376-X

7 January 2021

Thiazides and bone mineral density in elderly men and women

1 reference

https://api.crossref.org/works/10.1016/S1086-5802(16)30376-X

7 January 2021

10.1016/S1086-5802(16)30376-X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9782696 AND SRC:MED&resulttype=core&format=json

5 December 2019

1 reference